3.1. epidemiology. renal cell carcinoma represents around 3% cancers, highest incidence occurring western countries . 2020, estimated 431,288 new cases rcc globally, 138,611 europe . higher incidence europe north america hypothesized due higher prevalence small renal masses (srms) settings abdominal imaging ubiquitous. 2020, lithuania reported highest overall rate rcc, followed czechia, estimated age-standardised rates (asrs) 14.5/100,000 14.42/100,000, respectively. person living czechia 2.83% risk developing rcc . generally, last two decades recently, annual increase 2% incidence worldwide europe. 2022, worldwide mortality rcc 179,368 deaths (115,600 men 63,768 women), calculated global asr rate 1.8/100,000 . decrease mortality since 1980s scandinavian countries since early 1990s france, germany, austria, netherlands, italy. however, european countries (croatia, estonia, greece, ireland, slovakia), mortality rates still show upward trend . renal cell carcinoma common solid lesion within kidney accounts approximately 90% kidney malignancies. comprises different rcc subtypes specific histopathological genetic characteristics. 1.5â€“2.0:1 predominance men women higher incidence older population [4-6].